Skip to main content
Caplight Logo









Reselute

Reselute

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://reselutemedical.com/

Last Round

Seed Round

Jul 23, 2026

Total Funding Raised

$1.33M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Reselute is a therapeutic devices company that develops solutions for the treatment of orthopedic-related infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

drug-eluting implantslocalized antibiotic deliveryresorbable orthopedic implantsbioabsorbable implantsorthopedic implant infectionload-bearing implantsintramedullary nailbone infection treatmentIM nailtibial nailperiprosthetic joint infectionPJIfracture-related infectionsurgical site infectionSSIorthopedic spacersmedtechFDA Breakthrough Device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reselute Comparables

Compare Reselute with similar companies based on industry and business-model similarity.

Reselute comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Johnson & Johnson
78%
Silver Bullet Therapeutics, Inc.
78%
OrthoXel
77%

Reselute Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 23, 2026
Seed RoundApr 27, 2026
GrantJul 15, 2024
SeedMay 18, 2023
GrantSep 1, 2022
Grant
May 5, 2022

Key People

Founding team and executive leadership

Cambre Kelly

Chief Executive Officer

Executive Team

Fioleda Prifti Kesseli

Chief Technology Officer

Executive Team

Omar Alaa Eldeen

Chief Technology Officer

Executive Team

Reselute Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2026

    $1M raised in Seed Round.

  • Apr 27, 2026

    Raised $2.39M in Seed funding.

Reselute Filings

Explore SEC and related filing metadata, where available.

Reselute filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Reselute's valuation, stock price, and market status.

Is Reselute a public or private company?

Reselute is a private company.

What is the current stock price of Reselute?

Reselute is a private company, so its shares have no public market price. Caplight tracks Reselute's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Reselute worth (valuation)?

Valuation information for Reselute is not publicly available.

Can I buy Reselute stock?

Reselute shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Reselute's last funding round?

Reselute's most recent funding round was Seed Round on July 23, 2026.

Who are the main investors in Reselute?

Key investors in Reselute include Duke Capital Partners.

Will Reselute IPO soon?

No public IPO plans have been announced for Reselute.

How can I track Reselute secondary market activity?

Caplight tracks bids, offers, and trades in Reselute's shares on secondary markets.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range8
Year Founded2021
Last FundingJul 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?